🍽️ Methionine

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations    |     πŸ“ Dosage Seen

Data Contradictions β€” Limits of Certainity

Impacted of Methionine On Probiotics

Rank Probiotic Impact

Bacteria Impacted by Methionine

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Burkholderiaceae family Decreases 👪 Source Study
Lachnospiraceae family Decreases 👪 Source Study
Oscillospiraceae family Decreases 👪 Source Study
Desulfovibrionaceae family Increases 👪 Source Study
Burkholderia genus Decreases 📓 Source Study Pathogen
Coprococcus genus Decreases 📓 Source Study
Klebsiella genus Decreases 📓 Source Study Pathogen
Roseburia genus Decreases 📓 Source Study
Ruminococcus genus Decreases 📓 Source Study
Desulfovibrio genus Increases 📓 Source Study
environmental samples no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
Klebsiella/Raoultella group no rank Decreases 👪 Source Study
unclassified Burkholderia no rank Decreases 👶 Source Study
unclassified Coprococcus no rank Decreases 👶 Source Study
unclassified Klebsiella no rank Decreases 👶 Source Study
unclassified Roseburia no rank Decreases 👶 Source Study
unclassified Ruminococcus no rank Decreases 👶 Source Study
unclassified Desulfovibrio no rank Increases ⚗️ Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Desulfovibrio no rank Increases 👶 Source Study
Burkholderia gladioli species Decreases 👶 Source Study
Burkholderia glumae species Decreases 👶 Source Study
Burkholderia plantarii species Decreases 👶 Source Study
Burkholderia rinojensis species Decreases 👶 Source Study
Burkholderia sp. Bp5365 species Decreases 👶 Source Study
Burkholderia sp. OLGA172 species Decreases 👶 Source Study
Coprococcus catus species Decreases 👶 Source Study
Coprococcus comes species Decreases 👶 Source Study
Coprococcus eutactus species Decreases 👶 Source Study
Coprococcus phoceensis species Decreases 👶 Source Study
Klebsiella aerogenes species Decreases 👶 Source Study
Klebsiella africana species Decreases 👶 Source Study
Klebsiella granulomatis species Decreases 👶 Source Study
Klebsiella grimontii species Decreases 👶 Source Study
Klebsiella huaxiensis species Decreases 👶 Source Study H00301 Klebsiella infection
Klebsiella michiganensis species Decreases 👶 Source Study
Klebsiella oxytoca species Decreases 👶 Source Study
Klebsiella pasteurii species Decreases 👶 Source Study
Klebsiella pneumoniae species Decreases 👶 Source Study H00301 Klebsiella infection, Pneumonia
Klebsiella quasipneumoniae species Decreases 👶 Source Study H00301 Klebsiella infection
Klebsiella quasivariicola species Decreases 👶 Source Study H00301 Klebsiella infection
Klebsiella variicola species Decreases 👶 Source Study
Roseburia cecicola species Decreases 👶 Source Study
Roseburia faecis species Decreases 👶 Source Study
Roseburia hominis species Decreases 👶 Source Study
Roseburia intestinalis species Decreases 👶 Source Study
Roseburia inulinivorans species Decreases 👶 Source Study
Roseburia porci species Decreases 👶 Source Study
Roseburia rectibacter species Decreases 👶 Source Study
Roseburia yibonii species Decreases 👶 Source Study
Roseburia zhanii species Decreases 👶 Source Study
Ruminococcus albus species Decreases 👶 Source Study
Ruminococcus bicirculans (ex Wegman et al. 2014) species Decreases 👶 Source Study
Ruminococcus bovis species Decreases 👶 Source Study
Ruminococcus bromii species Decreases 👶 Source Study
Ruminococcus callidus species Decreases 👶 Source Study
Ruminococcus champanellensis species Decreases 👶 Source Study
Ruminococcus difficilis species Decreases 👶 Source Study
Ruminococcus flavefaciens species Decreases 👶 Source Study
Ruminococcus gauvreauii species Decreases 👶 Source Study
Ruminococcus hominis species Decreases 👶 Source Study
Ruminococcus intestinalis species Decreases 👶 Source Study
Ruminococcus turbiniformis species Decreases 👶 Source Study
Candidatus Desulfovibrio trichonymphae species Increases 👶 Source Study
Desulfovibrio aminophilus species Increases 👶 Source Study
Desulfovibrio biadhensis species Increases 👶 Source Study
Desulfovibrio caledoniensis species Increases 👶 Source Study
Desulfovibrio cuneatus species Increases 👶 Source Study
Desulfovibrio desulfuricans species Increases 👶 Source Study
Desulfovibrio fairfieldensis species Increases 👶 Source Study Bacteremia
Desulfovibrio ferrophilus species Increases 👶 Source Study
Desulfovibrio giganteus species Increases 👶 Source Study
Desulfovibrio inopinatus species Increases 👶 Source Study
Desulfovibrio intestinalis species Increases 👶 Source Study
Desulfovibrio lacusfryxellense species Increases 👶 Source Study
Desulfovibrio legallii species Increases 👶 Source Study
Desulfovibrio litoralis species Increases 👶 Source Study
Desulfovibrio longreachensis species Increases 👶 Source Study
Desulfovibrio oryzae species Increases 👶 Source Study
Desulfovibrio oviles species Increases 👶 Source Study
Desulfovibrio oxyclinae species Increases 👶 Source Study
Desulfovibrio piger species Increases 👶 Source Study
Desulfovibrio psychrotolerans species Increases 👶 Source Study
Desulfovibrio simplex species Increases 👶 Source Study
Desulfovibrio sp. FW1012B species Increases 👶 Source Study
Desulfovibrio subterraneus species Increases 👶 Source Study
Desulfovibrio vulgaris species Increases 👶 Source Study
Burkholderia cepacia complex species group Decreases 👶 Source Study
pseudomallei group species group Decreases 👶 Source Study

Impact of Methionine on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.2 -0.2
ADHD 1 1.4 -0.4
Age-Related Macular Degeneration and Glaucoma 0.5 0.3 0.67
Allergic Rhinitis (Hay Fever) 0.2 -0.2
Allergies 0.3 0.5 -0.67
Allergy to milk products 1.5 1.5
Alopecia (Hair Loss) 0.2 0.2 0
Alzheimer's disease 0.7 2.6 -2.71
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.7 0.7 0
Ankylosing spondylitis 0.3 1.5 -4
Anorexia Nervosa 1.3 -1.3
Antiphospholipid syndrome (APS) 0.7 0.7
Asthma 0.2 0.7 -2.5
Atherosclerosis 0.5 0.7 -0.4
Atrial fibrillation 1.5 0.6 1.5
Autism 2.5 3.2 -0.28
benign prostatic hyperplasia 0.2 -0.2
Bipolar Disorder 1 1.5 -0.5
Brain Trauma 1.1 -1.1
Carcinoma 1 0.5 1
Celiac Disease 0.2 0.7 -2.5
Cerebral Palsy 1 -1
Chronic Fatigue Syndrome 1 1.2 -0.2
Chronic Kidney Disease 1.2 -1.2
Chronic Lyme 0.5 -0.5
Chronic Obstructive Pulmonary Disease (COPD) 0.2 1.2 -5
Coagulation / Micro clot triggering bacteria 0.2 1 -4
Colorectal Cancer 1.8 1.8
Constipation 0.3 0.5 -0.67
Coronary artery disease 0.7 0.8 -0.14
COVID-19 1.3 2.7 -1.08
Crohn's Disease 3.3 2.8 0.18
cystic fibrosis 0.5 0.7 -0.4
deep vein thrombosis 0.2 1 -4
Depression 1.4 3 -1.14
Endometriosis 0.5 0.5 0
Epilepsy 0.2 0.2 0
erectile dysfunction 0.2 0.2 0
Fibromyalgia 0.5 0.3 0.67
Functional constipation / chronic idiopathic constipation 1.5 1 0.5
gallstone disease (gsd) 0.5 0.5 0
Generalized anxiety disorder 0.2 0.5 -1.5
giant cell arteritis 0.6 0.6
Glioblastoma 0.3 -0.3
Gout 0.7 -0.7
Graves' disease 0.7 -0.7
Hashimoto's thyroiditis 0.8 0.5 0.6
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.8 0.8
hyperglycemia 0.2 0.2
hypersomnia 0.5 0.5
hypertension (High Blood Pressure 1.2 2.6 -1.17
Hypothyroidism 0.2 0.8 -3
IgA nephropathy (IgAN) 0.2 0.2 0
Inflammatory Bowel Disease 0.5 1.8 -2.6
Insomnia 0.7 -0.7
Intelligence 1.2 1.2
Intracranial aneurysms 0.7 0.7
Irritable Bowel Syndrome 1.8 2.5 -0.39
Liver Cirrhosis 2.2 2.1 0.05
Long COVID 1.1 2.5 -1.27
Low bone mineral density 1.5 -1.5
Lung Cancer 0.8 -0.8
ME/CFS with IBS 0.5 -0.5
ME/CFS without IBS 0.2 -0.2
Menopause 0.2 -0.2
Metabolic Syndrome 2.5 2.6 -0.04
Mood Disorders 2.4 3 -0.25
Multiple Sclerosis 0.7 2 -1.86
Multiple system atrophy (MSA) 0.2 0.5 -1.5
Neuropathy (all types) 0.2 0.2
neuropsychiatric disorders (PANDAS, PANS) 0.2 -0.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.2 -1.2
Obesity 3.6 2.3 0.57
obsessive-compulsive disorder 1 0.7 0.43
Osteoarthritis 0.2 0.5 -1.5
Osteoporosis 0.5 0.5
pancreatic cancer 0.2 0.2
Parkinson's Disease 1.3 2.4 -0.85
Polycystic ovary syndrome 0.7 0.7 0
Postural orthostatic tachycardia syndrome 0.5 -0.5
primary biliary cholangitis 0.2 0.2 0
Psoriasis 0.5 1 -1
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.3 2 0.15
Rosacea 0.5 0.5 0
Schizophrenia 1.7 2.1 -0.24
scoliosis 0.8 0.5 0.6
sensorineural hearing loss 0.2 -0.2
Sjögren syndrome 0.2 -0.2
Sleep Apnea 1.2 1 0.2
Small Intestinal Bacterial Overgrowth (SIBO) 0.8 0.6 0.33
Stress / posttraumatic stress disorder 0.5 1.2 -1.4
Systemic Lupus Erythematosus 1.6 1.2 0.33
Tic Disorder 0.7 0.2 2.5
Tourette syndrome 0.2 -0.2
Type 1 Diabetes 1.2 0.7 0.71
Type 2 Diabetes 2.2 2.1 0.05
Ulcerative colitis 1.1 1.2 -0.09
Unhealthy Ageing 0.5 1.6 -2.2

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)